Lifshitz Law Firm Announces Class Action Lawsuits against Affymax, Inc., Impax Laboratories Inc., and Tangoe, Inc.

Lifshitz Law Firm Announces Class Action Lawsuits against Affymax, Inc., Impax
                     Laboratories Inc., and Tangoe, Inc.

PR Newswire

NEW YORK, March 18, 2013

NEW YORK, March 18, 2013 /PRNewswire/ --

Affymax, Inc.

Lifshitz Law Firm announces that a class action suit was filed in the United
States District Court for the Northern District of California, alleging that
Affymax, Inc. ("Affymax" or the "Company") (AFFY) issued false and misleading
statements to investors between December 8, 2011 and February 22, 2013 (the
"Class Period") by failing to adequately disclose: (1) that the Company's FY
2012 financial guidance was materially overstated; (2) that reported sales of
its primary drug product were not sustainable; and (3) that the defendants
were materially overstating sales and understating the potential liabilities
related to its primary drug product, including refunds and potential liability
to injured patients.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at
(212) 213-6222 Ext. 18 or by sending an e-mail including your contact
information to: info@jlclasslaw.com.

Impax Laboratories Inc.

Lifshitz Law Firm announces that a class action suit was filed in the United
States District Court for the Northern District of California on behalf of
purchasers of Impax Laboratories Inc. ("Impax" or the "Company") (IPXL)
between June 6, 2011 through March 4, 2013, inclusive (the "Class Period").
The Complaint alleges defendants misrepresented and/or failed to disclose that
at its Hayward facility: (1) the Company failed to maintain proper quality
control and manufacturing practices in violation of current GMP; (2) the
Company failed to take proper remedial actions to correct quality control
issues previously identified by the FDA in prior inspections; and (3) the
Company failed to disclose the extent of the adverse impact the manufacturing
deficiencies could have on the Company's ability to successfully launch its
new drug, Rytary.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at
(212) 213-6222 Ext. 18 or by sending an e-mail including your contact
information to: info@jlclasslaw.com.

Tangoe, Inc.

Lifshitz Law Firm announces that a class action suit was filed in the United
States District Court for the District of Connecticut on behalf of all persons
or entities who purchased Tangoe, Inc. ("Tangoe" or the "Company") (TNGO)
securities between December 20, 2011 and September 5, 2012 (the "Class
Period"). The Complaint alleges defendants misrepresented and/or failed to
disclose that (1) the Company was overstating organic growth by underreporting
the percentage of revenue derived from recent acquisitions; (2) the Company
was not growing customers organically as its deferred implementation fees
failed to grow; and (3) as a result of the above, the Company's financial
statements were materially false and misleading at all relevant times.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at
(212) 213-6222 Ext. 18 or by sending an e-mail including your contact
information to: info@jlclasslaw.com.

Lifshitz Law Firm is a New York based law firm with significant experience
representing investors in merger-related shareholder class actions,
shareholder derivative actions, and securities fraud class actions. For more
information about the firm, please visit our website at www.jlclasslaw.com.

ATTORNEY ADVERTISING. © 2013 Lifshitz Law Firm. The law firm responsible for
this advertisement is Lifshitz Law Firm, 18 East 41^st Street, New York, New
York 10017, (212) 213-6222. Prior results do not guarantee or predict a
similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone: 212-213-6222
Email: info@jlclasslaw.com



SOURCE Lifshitz Law Firm

Website: http://www.jlclasslaw.com